STADA, the German pharmaceutical giant,

STADA, the German pharmaceutical giant, will buy the drug production business of Ukraine’s Biopharma. For an undisclosed sum, STADA will buy factories in Bila Tserkva, 85 km south of Kyiv. An investment of Horizon Capital and Dutch development bank FMO, Biopharma now exports products to 36 countries. Peter Goldschmidt, STADA CEO, said: “We see great potential in the Ukrainian market. Thanks to this acquisition, we will become an important player in the Ukrainian pharmaceutical market with a strong local manufacturing presence.” Konstantin Efimenko, the managing partner of Biopharma, said: “This is the first investment by a strategic investor in the pharmaceutical industry in the history of Ukraine and the first European investment since 2014.”